View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Pertuzumab 840 / Trastuzumab 8, Tumor Biomarker Defined, Cycle 1
Protocol-ID: 1533 V1.1 (Mini), PERT840/TRAS8, Tumor Biomarker Defined, C1Indication(s)
- Bile Duct Carcinoma; ICD-10 C24.-, C24.0, C24.1, C24.8, C24.9
- Colon Cancer (HER2+); ICD-10 C18.0, C18.2, C18.3, C18.4, C18.5, C18.6, C18.7, C18.8, C19
- Tumor Biomarker Defined (HER2+)
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 08.02.2024